Publication date: Dec 06, 2024
Personal support workers (PSWs) are important healthcare workers providing essential services to thousands of Canadians. PSWs face many challenges that were exacerbated in the context of the COVID-19 pandemic. In this study we explore experiences of PSWs working through the pandemic in Ontario long-term care (LTC) homes by focusing on the vulnerability of such workers. An interpretive description approach was adopted. Eleven PSWs working in LTC homes in an urban center in Ontario participated in semi-structured interviews between January and May 2022. Thematic analysis of the transcripts was informed by concepts of vulnerability. The results suggest that PSWs experienced inherent, situational, and pathogenic vulnerability. Inherent vulnerability was experienced in relation to risks of contracting the coronavirus working in person with residents, and of experiencing physical and psychological distress in relation to challenging interactions with staff, residents and their superiors. Situational vulnerability was experienced in relation to demanding workloads, which were intensified in the context of the pandemic. Participants expressed feeling undervalued, unappreciated, and disrespected, reflecting experiences of pathogenic vulnerability. The narratives shared by PSWs highlighted how the COVID-19 pandemic added new, and magnified pre-existing, challenges and vulnerability, affecting their health and well-being. Understanding risks faced by PSWs in LTC settings is crucial for developing targeted interventions and policies to support PSWs’ health and well-being, mitigate factors that contribute to their vulnerability and promote the long-term sustainability of this caregiving workforce, ultimately enhancing the quality of care provided to residents in LTC facilities.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Canadians | COVID-19 |
| Healthcare | healthcare workers |
| Interviews | long-term care |
| January | occupational health |
| Pandemic | qualitative |
| vulnerability | |
| well-being |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 Pandemic |
| disease | MESH | psychological distress |
| drug | DRUGBANK | Etoperidone |
| disease | IDO | quality |
| drug | DRUGBANK | Coenzyme M |
| disease | IDO | role |
| disease | MESH | burnout |
| disease | MESH | violence |
| disease | MESH | moral injury |
| disease | MESH | infection |
| disease | IDO | facility |
| disease | IDO | process |
| drug | DRUGBANK | Pentaerythritol tetranitrate |
| disease | IDO | occurrent |
| drug | DRUGBANK | Trestolone |
| disease | MESH | dementia |
| drug | DRUGBANK | Nonoxynol-9 |
| disease | IDO | susceptibility |
| drug | DRUGBANK | Isoxaflutole |
| disease | MESH | anxiety |
| drug | DRUGBANK | Cysteamine |
| disease | MESH | emotional exhaustion |
| disease | MESH | emotional stress |
| drug | DRUGBANK | L-Phenylalanine |
| disease | MESH | Occupational stress |
| disease | MESH | depression |
| disease | MESH | emergency |
| disease | MESH | privacy |
| disease | IDO | intervention |
| drug | DRUGBANK | Delorazepam |
| drug | DRUGBANK | Aminosalicylic Acid |
| disease | MESH | Compassion Fatigue |
| disease | MESH | Uncertainty |